StockVS

纳斯达克 · USD

NEXGEL, Inc. (NXGLW) 股票分析

NEXGEL, Inc.(NXGLW)是在纳斯达克上市的股票,以美元交易。

NXGLW

$0.01

+$0.00 (+1.63%)

2026年9月4日 · 收盘

这是一只衍生品——NEXGEL, Inc.(NXGL)普通股的认股权证。

发行人的基本面数据显示在发行人页面,而非本页。

查看NXGL →

价格走势

悬停查看每日收盘价。虚线表示区间起始价。

NXGLW 关键统计数据

数据截至2026年9月4日
交易
开盘价
$0.31
前收盘价
$0.01
当日波动区间
0.01–0.02
52周波动区间
0.01–0.02
成交量
8.77K
Beta系数股价相对大盘的波动幅度。1.0与大盘同步,高于1.0波动更大,低于1.0更小。
0.75

仅显示公司披露的指标。 数据由Yahoo Finance通过yfinance提供。每日更新。

关于NEXGEL, Inc.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

公司简介以英文显示。

访问官网 →